Mechanism
ATXN2 (ataxin-2)
Assets acting on this target.
- Class
- ATXN2-lowering agent (modality not stated in source)
- Notes
- verified in session 2026-08-25 (owner-delegated review, correction of a wrong draft); source: https://clinicaltrials.gov/study/NCT04494256